Literature DB >> 8570314

MR marrow signs of iron overload in transfusion-dependent patients with sickle cell disease.

T L Levin1, S S Sheth, A Hurlet, S C Comerci, C Ruzal-Shapiro, S Piomelli, W E Berdon.   

Abstract

Magnetic resonance (MR) marrow signal in the axial and appendicular skeleton of 13 transfusion-dependent and chelated pediatric patients with sickle cell anemia (SSD) was compared with marrow signal in six non-transfusion-dependent patients with SSD. Hepatic, pancreatic, and renal MR signal were also evaluated. Indication for hypertransfusion therapy was primarily prior history of stroke. Transfusion-dependent patients had evidence of iron deposition throughout the imaged marrow and the liver, despite deferoxamine chelation therapy. Non-transfusion-dependent patients did not demonstrate grossly apparent signs of iron overload. Red marrow restoration was present in the spine, pelvis, and long bones and, in some patients, within the epiphyses. Marrow edema secondary to vaso-occlusive crises was evident in the metaphyses and diaphyses of long bones in areas of both red and fatty marrow and was best seen using fat-saturated T2-weighted imaging techniques.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8570314     DOI: 10.1007/bf02011829

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  10 in total

1.  Red and yellow marrow in the femur: age-related changes in appearance at MR imaging.

Authors:  S G Moore; K L Dawson
Journal:  Radiology       Date:  1990-04       Impact factor: 11.105

2.  Marrow infarction in sickle cell anemia: correlation with marrow type and distribution by MRI.

Authors:  V M Rao; D G Mitchell; M D Rifkin; R M Steiner; D L Burk; D Levy; S K Ballas
Journal:  Magn Reson Imaging       Date:  1989 Jan-Feb       Impact factor: 2.546

3.  Age-related changes in marrow distribution in the shoulder: MR imaging findings.

Authors:  M L Richardson; R M Patten
Journal:  Radiology       Date:  1994-07       Impact factor: 11.105

4.  Magnetic resonance imaging of bone marrow in sickle cell disease: clinical, hematologic, and pathologic correlations.

Authors:  V N Mankad; J P Williams; M D Harpen; E Manci; G Longenecker; R B Moore; A Shah; Y M Yang; B G Brogdon
Journal:  Blood       Date:  1990-01-01       Impact factor: 22.113

5.  Computed tomography of the spleen and liver in sickle cell disease.

Authors:  D Magid; E K Fishman; S S Siegelman
Journal:  AJR Am J Roentgenol       Date:  1984-08       Impact factor: 3.959

6.  Iron deposition in cranial bone marrow with sickle cell disease: MR assessment using a fat suppression technique.

Authors:  K Kaneko; J H Humbert; M S Kogutt; A E Robinson
Journal:  Pediatr Radiol       Date:  1993

7.  Epiphyseal marrow in infancy: MR imaging.

Authors:  D Jaramillo; T Laor; F A Hoffer; D J Zaleske; R H Cleveland; B R Buchbinder; T K Egglin
Journal:  Radiology       Date:  1991-09       Impact factor: 11.105

8.  An unusual scintigraphic pattern in sickle cell patients.

Authors:  A M Glaser; D C Chen; M E Siegel; S L Norris; L J Haywood
Journal:  Eur J Nucl Med       Date:  1989

9.  Abdominal iron distribution in sickle cell disease: MR findings in transfusion and nontransfusion dependent patients.

Authors:  E S Siegelman; E Outwater; C A Hanau; S K Ballas; R M Steiner; V M Rao; D G Mitchell
Journal:  J Comput Assist Tomogr       Date:  1994 Jan-Feb       Impact factor: 1.826

10.  Transfusional hemosiderosis in sickle cell anemia: another cause of an echogenic pancreas.

Authors:  M A Flyer; J O Haller; R Sundaram
Journal:  Pediatr Radiol       Date:  1993
  10 in total
  2 in total

1.  Bone marrow changes in beta-thalassemia major: quantitative MR imaging findings and correlation with iron stores.

Authors:  Eleni E Drakonaki; Thomas G Maris; Alex Papadakis; Apostolos H Karantanas
Journal:  Eur Radiol       Date:  2006-12-16       Impact factor: 7.034

2.  Tissue Iron Distribution Assessed by MRI in Patients with Iron Loading Anemias.

Authors:  Lucía Gutiérrez; Michael J House; Nisha Vasavda; Emma Drašar; Isabel Gonzalez-Gascon Y Marin; Austin G Kulasekararaj; Tim G St Pierre; Swee L Thein
Journal:  PLoS One       Date:  2015-09-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.